Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group (Q77917889)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

12

P Rutgeerts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

G Hellers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Jewell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C E Leijonmarck

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R Löfberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

H Malchow

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

L G Nilsson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Pallone

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Pena

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T Persson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Prantera

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

294-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

Maintenance of symptomatic remission in patients with Crohn's disease

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

A comparison of budesonide with prednisolone for active Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Should all Crohn's patients receive prophylactic medication after surgical resection? No

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

Classification of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970125-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(99)70125-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922309%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference